Hussman Strategic Advisors, Inc. United Therapeutics Corp Transaction History
Hussman Strategic Advisors, Inc.
- $320 Million
- Q4 2024
A detailed history of Hussman Strategic Advisors, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 8,400 shares of UTHR stock, worth $2.92 Million. This represents 0.93% of its overall portfolio holdings.
Number of Shares
8,400
Previous 6,300
33.33%
Holding current value
$2.92 Million
Previous $2.26 Million
31.28%
% of portfolio
0.93%
Previous 0.59%
Shares
15 transactions
Others Institutions Holding UTHR
# of Institutions
692Shares Held
60.6MCall Options Held
194KPut Options Held
298K-
Wealthfront Advisers LLC18.3MShares$6.37 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$1.9 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.53 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.1 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$994 Million15.42% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $15.8B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...